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Abstract: Osteoarthritis (OA) is a degenerative condition of joints, causing pain and swelling, and can
be caused or worsened by trauma and obesity. The objectives of this study were to determine whether
pain behaviour and progression of OA were increased in rats with trauma-induced OA fed dietary
saturated fatty acids (SFA). Male Wistar rats were fed either a corn starch diet (C) or high-carbohydrate
high-fat diet (H) with either 20% beef tallow or SFA (lauric (HLA), myristic (HMA), palmitic (HPA) or
stearic (HSA) acids) for 16 weeks prior to and 8 weeks after excision of the medial meniscus of right
knee joint to initiate OA when pain behaviour, glial activity, progression of knee OA, inflammatory
mediators and signs of metabolic syndrome were assessed. Rats fed beef tallow, palmitic or stearic
acids showed increased pain symptoms characterised by decreased hind paw/limb withdrawal
thresholds and grip strengths and increased spinal astrogliosis and microgliosis compared to rats
fed lauric or myristic acids. However, the severity of OA joint damage was unchanged by these
dietary manipulations. We conclude that pain symptoms of trauma-induced OA in rats worsen with
increased dietary beef tallow or palmitic or stearic acids, but improve with lauric or myristic acids,
despite unchanged OA cartilage damage.
Keywords: osteoarthritis; saturated fatty acids; pain; obesity; diet; cartilage
1. Introduction
Trauma is an important cause of osteoarthritis (OA), a complex multifactorial disease process
leading to degeneration of joints [1]. In the 2017/2018 Australian Bureau of Statistics National Health
Survey, 12% of females and 6.8% of males (2.2 million Australians) had arthritis with an economic
impact of $3.5 billion annually [2]. The characteristic features of OA include degradation of the
cartilage and sclerosis of subchondral bone, with increased synovial inflammation playing a major
role in the degenerative bone disease [1,3,4]. Pro-inflammatory mediators may be released by the
infrapatellar fat pad to stimulate proliferation of inflammatory cells in the synovial membrane, driving
peripheral and central sensitisation in knee osteoarthritis [5]. The major symptom of OA is pain,
which eventually leads to disability with increasing disease progression [6]. Complex mechanisms
drive OA pain. These include activation of mechano-transducers and acid-sensing ion channels on
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sensory nerve fibres, sensitisation, transcriptional changes, and ectopic sprouting of sensory nerve
fibre and central sensitisation involving both the spinal cord and brain [7]. Throughout the entire
nociceptive pathway, glial cells such as astrocytes and microglia become activated after nerve injury
and inflammation in the central nervous system [8]. This activation regulates chronic pain by changing
glial cell morphology and releasing pro-inflammatory cytokines, which induce the proliferation of
other glial cells and enhance transmission of pain [9,10].
Obesity, a major risk factor for OA [11], is characterised by chronic low-grade inflammation leading
to excess fat deposition in adipose tissue, dyslipidaemia, hypertension, mitochondrial dysfunction
and hyperglycaemia [12] which may then produce muscle damage and musculoskeletal complications
including OA [13,14]. Our recent studies showed that synovial resident macrophages produce systemic
and joint inflammation before cartilage damage in obese rats fed a high-carbohydrate high-fat diet [15].
Furthermore, we showed that saturated fatty acids (SFA) such as palmitic or stearic acids as long-chain
SFA caused pronounced OA and metabolic syndrome, in contrast to the minimal effects of lauric and
myristic acids as medium-chain SFA [16].
As increased consumption of long-chain SFA is a relevant risk factor for both metabolic syndrome
and OA, we have examined the role of the different dietary SFA in the development of pain-related
behaviour in trauma-induced OA. We hypothesised that increased dietary intake of these SFA might
alter the pain symptoms in trauma-induced OA, with responses depending on chain length. This
study assessed post-traumatic pain sensitisation behaviour and possible changes in joint structure
following meniscectomy in rats fed diets with different medium-chain or long-chain SFA.
2. Materials and Methods
2.1. Rats and Diets
The experimental groups consisted of 36 male Wistar rats 8–9 weeks of age weighing 340 ± 2 g
purchased from Animal Resource Centre, Murdoch, WA, Australia. The rats were randomly divided
into six groups and were individually housed at the University of Southern Queensland Animal
House in a temperature-controlled, 12 h light/dark cycle environment with free access to water and
experimental diets. All animal procedures were approved by the Animal Ethics Committees of the
Queensland University of Technology (Approval number 1500000117) and the University of Southern
Queensland (Approval number 14REA010) under the guidelines of the National Health and Medical
Research Council of Australia.
Rats were fed for 16 weeks either with a corn starch diet (C) or with a high-carbohydrate high-fat
diet (H) [17]. The C diet contained 570 g of corn starch, 155 g of powdered rat food (Specialty Feeds,
Glen Forest, WA, Australia), 25 g of Hubble, Mendel and Wakeman salt mixture (MP Biomedicals,
Seven Hills, NSW, Australia), and 250 g of water per kilogram of diet. The H diet contained 175 g
of fructose, 395 g of sweetened condensed milk, 200 g of beef tallow (all obtained from local food
suppliers and supermarkets), 155 g of powdered rat food, 25 g of Hubble, Mendel and Wakeman salt
mixture, and 50 g of water per kilogram of diet. In separate rat groups, beef tallow was replaced by
200 g per kilogram of diet with an SFA (lauric acid (HLA), myristic acid (HMA), palmitic acid (HPA),
or stearic acid (HSA)). C rats were given drinking water without any additives while drinking water
for H-based diets was supplemented with 25% fructose [17]. The carbohydrate intake in both C and
H groups was approximately 68%. Measurements of body weight and food and water intakes were
taken daily.
2.2. Surgery
After 16 weeks of the diets, rats were anaesthetised by intraperitoneal injection of Zoletil (tiletamine
15 mg/kg, zolazepam 15 mg/kg; Virbac, Peakhurst, NSW, Australia) and Xylazil (xylazine 10 mg/kg;
Troy Laboratories, Smithfield, NSW, Australia) and partial medial meniscectomy of the right knee
was performed [18]. The separate group of sham-operated rats was subjected to a similar surgical
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procedure in the right knee, except that the ligament and meniscus were not excised or manipulated.
After the conclusion of the surgery, all rats received buprenorphine 0.05 mg/kg and gentamicin 5 mg/kg.
Rats were allowed to recover for 1 week, during which time they were placed on a standard rat chow
diet and given post-surgical medications. Once rats had recovered, they were placed on the same diet
as before the surgery for a further period of 8 weeks.
2.3. Metabolic, Cardiovascular, and Liver Parameters
Feed efficiency and energy intakes were calculated from food and water intakes [17]. Abdominal
circumference was measured using a standard measuring tape under light anaesthesia with Zoletil
(tiletamine 10 mg/kg, zolazepam 10 mg/kg i.p; Virbac). An oral glucose tolerance test was performed
on rats at the end of the protocol after overnight food deprivation [17]. Systolic blood pressure was
measured under light sedation with Zoletil (tiletamine 10 mg/kg, zolazepam 10 mg/kg, i.p.) [17].
Dual-energy X-ray absorptiometry measurements were performed on all rats using a Norland XR-46
Bone Densitometer Machine (Norland Corp., Fort Atkinson, WI, USA) under light sedation with Zoletil
(tiletamine 10 mg/kg, zolazepam 10 mg/kg; Virbac) by intraperitoneal injection at the end of 8 weeks
and 16 weeks. Scans were examined using the manufacturer’s recommended software for use in
laboratory animals (Small Subject Analysis Software, version 2.5.3/1.3.1; Norland Corp.). Body mass
index was calculated as g/cm2.
Rats were euthanised after 25 weeks using Lethabarb® (100 mg/kg pentobarbitone sodium, i.p.;
Virbac). After euthanasia, blood was collected to separate plasma and the plasma was stored at
−20 ◦C for further analysis. Hearts were isolated to perform Langendorff heart preparation to measure
diastolic stiffness [17]. Following this, tissues such as liver, left ventricle (with septum), right ventricle
and abdominal fat (including retroperitoneal, epididymal and omental) were removed for weighing
and expressed as mg/mm of tibial length. Plasma concentrations of total cholesterol, triglycerides and
non-esterified fatty acids (NEFA), and plasma activities of alanine transaminase (ALT) and aspartate
transaminase (AST) were measured [17].
2.4. Pain Behaviour
2.4.1. von Frey Test
The rats were placed in cages with a metallic mesh base, 20 cm above the bench. A habituation
period of 15 min was allowed before the test. The von Frey filaments (BIO-VF-M, Bioseb, Vitrolles,
France) were placed on the paw and the withdrawal threshold was determined by applying force
ranging from 2–20 g. The paw sensitivity threshold was defined as the minimum gentle touch
required to elicit a robust and immediate withdrawal of the paw. Positive responses included a sudden
withdrawal of hind paw or flinching behaviour in response to the removal of the filaments. Voluntary
movements which were associated with locomotion were not taken as a positive withdrawal response.
The von Frey filaments were applied on each anterior paw with an interval of 5 s. The measurement
was taken 3 times and the final value was obtained by averaging the 3 readings. A threshold of 6 g was
chosen as an indication of allodynia.
2.4.2. Hind Limb Grip Strength
Hind limb grip strength was measured with a rat grip strength meter (BIO-GS3, Bioseb, Vitrolles,
France). Each rat was gently restrained by grasping the area around its rib cage and then was allowed
to hold on to the wire mesh frame attached to the grip meter. The operator then moved the animal in a
rostral-to-caudal direction until the rat lost the grip of the mesh frame. Each rat was measured 3 times
at approximately 2 min interval to obtain the mean grip force (g).
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2.4.3. Pressure Application Measurement (PAM)
A PAM device (BIO SMALGO, Bioseb, Vitrolles, France) was used to measure the mechanical
pain threshold of the knee joint. The instrument consisted of a calibrated force sensor that is worn
on the operator’s thumb. The rate of application of the force is decided by the operator and the force
(g) required to elicit the response (withdrawal of the limb) was recorded as a positive reading. Three
consecutive measurements were taken at intervals of 5 s.
2.5. Assessment of Articular Cartilage, Subchondral Bone, Lumbar Spinal Cords, and Dorsal Root Ganglia
After euthanasia, the knee joints were harvested. Micro-CT was performed to analyse the
subchondral bone changes. Tibia were scanned using a micro-CT (Scanco µCT 40, Scanco Medical,
Switzerland) and then processed for histology [16]. Mankin scoring was performed to assess the
severity of the cartilage damage [16]. The mean Mankin score from 5–6 samples from each animal
was used to determine the mean ± standard deviation for each group. Two independent observers
assessed cartilage damage in a blinded manner.
After euthanasia, lumbar spinal cords (SC) and dorsal root ganglia (DRG) were removed
(n = 4 per group) and rinsed in phosphate-buffered saline and later post-fixed in 4% paraformaldehyde
for 3 h. The fixed SC and DRG tissues were then embedded in paraffin and sectioned into 6 µm
sections for immunofluorescence analysis. The lumbar SC and DRG (n = 4 per group) were rinsed in
phosphate-buffered saline and stored in RNA Later solution (Ambion 7024) for real-time PCR analysis.
The SC and DRG sections underwent immunofluorescence analysis of glial fibrillary acidic
protein (GFAP) [18] and ionised calcium binding adaptor molecule-1 (Iba-1) [19], which label the
activated astrocytes and microglia, respectively. Briefly, the sections were deparaffinised in xylene and
rehydrated in decreasing concentrations of ethanol. The tissue slices were first permeabilised with
proteinase K for 30 min at 37 ◦C. The sections were then incubated with rabbit anti-GFAP (1:500, Abcam-
ab7260) for 1 h at room temperature or with goat anti-Iba-1 (1; 500, Abcam-ab5076) for 1 h at room
temperature. After primary antibody incubation, the sections were incubated with the appropriate
secondary antibody (1:300, Goat anti-rabbit Alexa 488 or 1:300, Donkey anti-goat TR 566) for 1 h at
room temperature. The sections were then cover-slipped using ProLong Gold Antifade Mountant
with DAPI (4′,6-diamidino-2-phenylindole, P36935, ThermoFisher, Australia). For controls, the same
procedures were carried out either without primary antibody or with isotype-matched IgG instead of
primary antibody.
2.6. RNA Extraction and Real-time PCR
Total RNA was extracted using TRIzol reagent (15596018, Invitrogen). Real-time quantitative
PCR [20] using SYBR Green detection was performed on the ABI 7500 Fast Real-Time PCR system
(Applied Biosystems, Foster City, CA, USA). The primers used were GFAP (NCBI Reference Sequence
ID: NM_017009, Gene ID: 24387) and AIF1 (NCBI Reference Sequence ID: NM_017196, Gene ID: 29427).
All samples were measured in triplicate and the mean value of all experimental samples was calculated
for comparative analysis. Quantitative measurements of all primers used in this study were determined
using the (2−∆Ct) method, and 18S and β-actin expression were used as the internal controls [18,20,21].
2.7. Quantification of Inflammatory Markers
Blood plasma was stored frozen for later measurements of inflammatory markers using
enzyme-linked immunosorbent assay (ELISA; R&D Systems, Australia). Plasma samples were
thawed on ice and processed as per manufacturer’s protocol. Concentrations of IL-1β, IFN-γ and IL-10
were quantified by ELISA (rat IL-1β, IFN-γ and IL-10 Quantikine; R&D Systems, In Vitro Technologies
Pty Ltd., Noble Park, VIC, Australia).
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2.8. Statistical Analysis
Statistical analyses were performed using GraphPad Prism 7.0. The data are presented as the
mean ± standard error of the mean (SEM) for metabolic data and standard deviation (SD) for bone
data and were analysed with ANOVA method. Repeated-measures analysis of variance with post hoc
tests (Dunnett’s/Bonferroni) was used to assess statistical significance. The level of significance was set
at p < 0.05.
3. Results
3.1. Metabolic, Cardiovascular and Liver Parameters
At 25 weeks, the body weights of HPA, HMA and HSA rats were not different to that of H diet rats
but were greater than C rats. In contrast, HLA rats showed a markedly smaller increase in body weight
than H, HMA, HLA and HSA rats (Figure 1A). Plasma IL-1β and IFN-γ concentrations were higher and
similar in H, HPA and HSA rats than that in C rats. Both HLA and HMA rats had lower concentrations
of both inflammatory markers in comparison to H rats (Figure 1B,C). In contrast, concentrations of the
anti-inflammatory cytokine, IL-10, were higher in C, HLA and HMA rats than in H, HPA and HSA rats
(Figure 1D).
Nutrients 2019, 11, x FOR PEER REVIEW 5 of 16 
 
Statistical analyses were performed using GraphPad Prism 7.0. The data are presented as the 
mean ± standard error of the mean (SEM) for metabolic data and standard deviation (SD) for bone 
data and were analysed ith ANOVA method. Repeated-measures analysis of variance with post 
hoc tests (Dunnett’s/Bonferroni) was used to assess statistical significance. The level of significance 
was set at p < 0.05. 
3. Results 
3.1. Metabolic, Cardiovascular and Liver Parameters 
At 25 weeks, the body weights of HPA, HMA and HSA rats were not different to that of H diet 
rats but were greater than C rats. In contrast, HLA rats showed a markedly smaller increase in body 
weight than H, HMA, HLA and HSA rats (Figure 1A). Plasma IL-1β and IFN-γ concentrations were 
higher and similar in H, HPA and HSA rats than that in C rats. Both HLA and HMA rats had lower 
concentrations of both inflammatory markers in comparison to H rats (Figures 1B,C). In contrast, 
concentrations of the anti-inflammatory cytokine, IL-10, were higher in C, HLA and HMA rats than 
in H, HPA and HSA rats (Figure 1D). 
 
Figure 1. Weight gain and inflammatory markers in rat plasma. (A) Body weight of rats fed with the 
different saturated fatty acid diets for a period of 25 weeks (Dotted line showing the week of surgery); 
n = 6. * indicate p < 0.05 H vs. C, HLA, HMA, HPA and HPA. Plasma pro-inflammatory cytokine IL-
1β (B), IFN-γ (C) and anti-inflammatory cytokine IL-10 (D) concentrations in different saturated fatty 
acids diet-fed rats. All values are represented as mean ± SD, n = 6; p < 0.05. C, corn starch diet-fed rats; 
H, high-carbohydrate high-fat diet-fed rats; HLA, high-carbohydrate high-lauric acid diet-fed rats; 
HMA, high-carbohydrate high-myristic acid diet-fed rats; HPA, high-carbohydrate high-palmitic acid 
diet-fed rats; HSA, high-carbohydrate high-stearic acid diet-fed rats. 
Food intake was higher in C rats compared to all other groups while HLA rats had the lowest 
food intake. Water intake was higher in HLA, HPA and HSA rats compared to the other three groups 
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Figure 1. Weight gain and inflammatory markers in rat plasma. (A) Body weight of rats fed with the
different saturated fatty acid diets for a period of 25 weeks (Dotted line showing the week of surgery);
n = 6. * indicate p < 0.05 vs. C, HLA, HMA, HPA and HPA. Plasma pro-inflammatory cytokine
IL-1β (B), I - ( ) and anti-infla matory cytokine IL-10 (D) concentrations i different saturated
fatty acids diet-fed rats. All values are represented as mean ± SD, n = 6; p < 0.05. C, corn starch diet-fed
rats; , igh-carbohydrate high-fat diet-fed rats; HLA, igh-carbohydrate high-lauric acid diet-fed rats;
HMA, high-carbohydrate high-myristic acid diet-fed rats; HPA, high-carbohydrate high-palmitic acid
diet-fed rats; HSA, high-carbohydrate high-stearic acid diet-fed rats.
Food intake was higher in C rats compared to all other groups while HLA rats had the lowest
food intake. Water intake was higher in HLA, HPA and HSA rats compared to the other three groups
(Table 1). Energy intake was in the order of HPA = HSA > HMA = HLA = H > C. Feed efficiency
was higher in H rats compared to HMA and HPA rats which was higher than in C, HLA and HSA
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rats (Table 1). H, HMA and HPA rats had higher abdominal circumference compared to C and HLA
rats, whereas HSA rats had intermediate abdominal circumference (Table 2). Total abdominal fat was
higher in H, HMA and HPA rats compared to C, HLA and HSA rats (Table 2). Bone mineral density
was higher in H rats compared to HSA rats, while other groups had intermediate bone mineral density.
Bone mineral content was higher in HPA rats compared to HMA rats, and H rats had intermediate
bone mineral content with HPA and HMA rats. C, HLA and HSA rats had lower bone mineral content
compared to other groups (Table 2).
Table 1. Dietary parameters in rats treated with fatty acids.
Variables C H HLA HMA HPA HSA
Initial body weight, g 340 ± 2ab 336 ± 0b 340 ± 2ab 336 ± 1b 344 ± 3a 337 ± 1b
Final body weight, g 446 ± 10b 571 ± 11a 460 ± 12b 553 ± 15a 591 ± 22a 492 ± 8b
Body weight gain, g 106 ± 10c 235 ± 11a 120 ± 11bc 217 ± 15a 247 ± 20a 155 ± 8b
Food intake, g/d 38.1 ± 1.3a 25.7 ± 0.3cd 23.8 ± 1.1d 27.2 ± 1.1bcd 30.7 ± 1.0b 29.4 ± 1.5bc
Water intake, mL/d 25.6 ± 2.4b 23.3 ± 1.3b 37.9 ± 2.3a 28.8 ± 1.4b 34.7 ± 1.0a 33.8 ± 0.8a
Energy intake, kJ/d 428 ± 14c 548 ± 9b 571 ± 19b 596 ± 23b 681 ± 21a 654 ± 28a
Feed efficiency, g/kJ 0.25 ± 0.02c 0.43 ± 0.02a 0.21 ± 0.02c 0.36 ± 0.02b 0.36 ± 0.02b 0.24 ± 0.01c
All values are mean ± SEM, n = 6. Mean values within a row with a different superscript (a, b, c, or d) are significantly
different, p < 0.05. C, corn starch diet-fed rats; H, high-carbohydrate high-fat diet-fed rats; HLA, high-carbohydrate
high-lauric acid diet-fed rats; HMA, high-carbohydrate high-myristic acid diet-fed rats; HPA, high-carbohydrate
high-palmitic acid diet-fed rats; HSA, high-carbohydrate high-stearic acid diet-fed rats.
Table 2. Metabolic parameters in rats treated with fatty acids.
Variables C H HLA HMA HPA HSA
Abdominal circumference, cm 19.8 ± 0.2d 23.6 ± 0.1ab 21.1 ± 0.5c 22.9 ± 0.4ab 23.8 ± 0.6a 22.3 ± 0.2b
Retroperitoneal fat, mg/mm* 190 ± 25b 489 ± 34a 201 ± 11b 389 ± 42a 379 ± 37a 272 ± 34b
Epididymal fat, mg/mm* 97 ± 8.9c 231 ± 15a 110 ± 13c 221 ± 11a 208 ± 17a 163 ± 24b
Omental fat, mg/mm* 144 ± 18c 261 ± 33a 133 ± 11c 229 ± 19ab 207 ± 19abc 163 ± 16bc
Abdominal fat pads, mg/mm* 431 ± 50b 981 ± 76a 444 ± 25b 840 ± 60a 794 ± 60a 598 ± 67b
Bone mineral density, g/cm2 0.185± 0.004ab 0.193± 0.005a 0.186± 0.003ab 0.186± 0.004ab 0.189± 0.003ab 0.176± 0.004b
Bone mineral content, g 12.9 ± 0.5c 16.7 ± 0.6ab 13.2 ± 0.6c 15.3 ± 0.6b 17.5 ± 0.70a 13.0 ± 0.4c
Total fat mass, g 98 ± 13c 209 ± 20a 105 ± 15c 205 ± 20a 231 ± 22a 129 ± 15c
Total lean mass, g 329 ± 5 350 ± 17 348 ± 9 333 ± 19 339 ± 12 359 ± 20
Blood glucose AUC, mmol/L×min 720 ± 39ab 773 ± 26a 644 ± 24b 653 ± 18b 720 ± 20ab 638 ± 23b
Fasting blood glucose, mmol/L 3.5 ± 0.5 4.6 ± 0.2 3.6 ± 0.3 4.0 ± 0.3 4.6 ± 0.3 4.2 ± 0.3
Blood glucose at 120 min, mmol/L 5.2 ± 0.2ab 6.3 ± 0.3a 4.9 ± 0.3b 5.0 ± 0.3b 5.3 ± 0.3ab 5.2 ± 0.2ab
Plasma NEFA, mmol/L 1.46 ± 0.19b 3.58 ± 0.56a 2.04 ± 0.44ab 3.25 ± 0.53a 3.47 ± 0.28a 3.40 ± 0.56a
Plasma triglycerides, mmol/L 0.51 ± 0.04b 1.33 ± 0.17ab 0.56 ± 0.12b 1.71 ± 0.40a 1.55 ± 0.32ab 1.11 ± 0.23ab
Plasma total cholesterol, mmol/L 1.41 ± 0.05 1.61 ± 0.11 1.46 ± 0.05 1.64 ± 0.08 1.63 ± 0.03 1.34 ± 0.08
All values are mean ± SEM, n = 6. Mean values within a row with a different superscript (a, b, c or d) are significantly
different, p < 0.05. C, corn starch diet-fed rats; H, high-carbohydrate high-fat diet-fed rats; HLA, high-carbohydrate
high-lauric acid diet-fed rats; HMA, high-carbohydrate high-myristic acid diet-fed rats; HPA, high-carbohydrate
high-palmitic acid diet-fed rats; HSA, high-carbohydrate high-stearic acid diet-fed rats; AUC, area under the curve;
NEFA, non-esterified fatty acids. *Weight normalised to tibial length.
Total body fat mass was higher in H, HMA and HPA rats compared to the other 3 groups.
Lean mass was unchanged among the groups (Table 2). Basal blood glucose concentrations were
unchanged between the groups due to higher variability within the groups. However, H rats showed
higher area under the curve suggesting impaired glucose tolerance (Table 2). H, HMA, HPA and HSA
rats had higher plasma concentrations of triglycerides and NEFA, whereas plasma total cholesterol
concentrations were unchanged among the groups (Table 2). Systolic blood pressures were higher
in H, HMA, HPA and HSA rats than in C and HLA rats (Table 3). Left ventricular diastolic stiffness
was lower in C and HLA rats compared to other groups while left ventricular weight was higher in
H rats compared to C and HLA rats, and it was intermediate in HMA, HPA and HSA rats (Table 3).
Right ventricular weights were unchanged among the groups (Table 3). Liver weights were higher in
H, HMA and HPA rats compared to the three other groups, whereas plasma activities of ALT and AST
were unchanged among the groups (Table 3).
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Table 3. Cardiovascular and liver parameters in rats treated with fatty acids.
Variables C H HLA HMA HPA HSA
Systolic blood pressure, mmHg 128 ± 3b 153 ± 4a 119 ± 4b 149 ± 9a 152 ± 5a 154 ± 4a
LV diastolic stiffness constant (k) 20.2 ± 1.2 23.2 ± 1.3 20.6 ± 1.6 23.8 ± 0.5 22.3 ± 1.6 24.2 ± 0.5
LV + Septum wet weight, mg/mm* 21.2 ± 1.0b 26.0± 1.3a 20.9 ± 1.0b 25.3± 0.9ab 23.8 ± 1.4ab 23.4± 1.1ab
RV wet weight, mg/mm* 5.28 ± 0.88 5.31± 0.22 5.04 ± 0.43 4.67± 0.35 4.78 ± 0.48 5.10± 0.24
Liver wet weight, mg/mm* 236 ± 10b 345 ± 13a 267 ± 17b 350 ± 11a 325 ± 16a 263± 3.0b
Plasma ALT, U/L 34.1 ± 7.7 28.5 ± 2.1 28.4 ± 7.1 32.6 ± 3.9 21.4 ± 1.5 35.1 ± 6.9
Plasma AST, U/L 78.2 ± 4.8 74.6 ± 8.2 71.9 ± 7.5 80.4 ± 8.7 62.8 ± 1.7 70.5 ± 4.0
All values are mean ± SEM, n = 6. Mean values within a row with a different superscript (a or b) are significantly
different, p < 0.05. C, corn starch diet-fed rats; H, high-carbohydrate high-fat diet-fed rats; HLA, high-carbohydrate
high-lauric acid diet-fed rats; HMA, high-carbohydrate high-myristic acid diet-fed rats; HPA, high-carbohydrate
high-palmitic acid diet-fed rats; HSA, high-carbohydrate high-stearic acid diet-fed rats; ALT, Alanine transaminase;
AST, Aspartate transaminase; LV, left ventricle; RV, right ventricle. *Weight normalised to tibial length.
3.2. Pain Behaviour Post-Meniscectomy
The contralateral paws of rats in all groups were not different from each other at all time points
and for all behavioural tests; furthermore, sham rats did not differ from control rats.
Medial meniscectomy to the ipsilateral knee induced mechanical hypersensitivity in comparison
to the sham-operated knee. Rats with medial meniscectomy developed tactile allodynia measured by
von Frey tests at week 1 after surgery. From week 2 to week 8, the paw withdrawal threshold (PWT) of
C rats was higher than that of the H rats, while the PWT of the HPA and HSA rats did not change
from week 3 to week 8, and also exhibited similar allodynia in comparison to the H rats, suggesting
increased pain perception in these three groups. The HMA rats had PWT readings similar to that
of the H rats. In contrast, the HLA rats showed increased PWT in comparison to H rats (Figure 2A).
Similar changes were observed in terminal week (week 8) measurements, whereas in HLA rats showed
increased PWT compared to other SFA diet-fed rats (Figure 2D).
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compared to H rats, whereas the HPA and HSA rats showed no changes compared to H rats (Figure 
3B). Consistent with BV/TV results, BMD decreased in H rats in comparison with C rats. HPA and 
HSA rats showed BMD similar to H rats, while HLA and HMA rats showed increased BMD 
compared to H rats (Figure 3C). 
Knees from post-meniscectomy rats exhibited OA-phenotypical cartilage changes, indicated by 
increased degeneration of the cartilage layer, loss of proteoglycans and fibrillation, whereas the 
sham-operated knees showed a normal appearance of the cartilage without any degeneration or 
subchondral bone changes (Figure 4A). In the sham group, the joints from the C rats showed smooth 
articular cartilage surface, normal cellularity and strong intensity of safranin-O staining. In contrast, 
sham-operated H, HPA and HSA rats showed degenerative changes of the articular cartilage 
especially in the surface zone, indicated by surface irregularity, loss of proteoglycans evidenced by 
weak safranin-O staining and increased Mankin scores. In contrast, HMA and HLA sham-operated 
rats showed cartilage structures, proteoglycan intensity and Mankin scores that were similar to C rats 
(Figures 4A,B). 
In post-meniscectomy rats, the joints were not visibly different, as all groups exhibited similar 
damage (Figure 4A). Post-meniscectomy rats demonstrated erosion of the hyaline cartilage with 
increased loss of proteoglycans from the extracellular matrix, as evident by the marked reduction of 
safranin-O staining and increased Mankin scores compared to sham rats, independent of SFA 
treatment (Figures 4A,B). The articular surface of post-meniscectomy rats of H, HLA, HMA, HPA 
and HSA groups showed similar fissures, fibrillation and exposure of the subchondral bone, as well 
as the formation of cysts and presence of osteophytes. 
Figure 2. Evaluation of pain behaviour. Changes in the hind paw withdrawal threshold (A), grip strength
(B) and limb withdrawal threshold (C) in rats fed with different saturated fatty acid diets for a period
of 8 weeks post-surgery. Week 8 changes in hind paw withdrawal threshold (D), grip strength (E),
and limb withdrawal threshold (F) in rats fed with the different saturated fatty acid diets. All values are
represented as mean ± SD, n = 6. C, corn starch diet-fed rats; H, high-carbohydrate high-fat diet-fed
rats; HLA, high-carbohydrate high-lauric acid diet-fed rats; HMA, high-carbohydrate high-myristic
acid diet-fed rats; HPA, high-carbohydrate high-palmitic acid diet-fed rats; HSA, high-carbohydrate
high-stearic acid diet-fed rats.
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Consistent with von Frey results, rats showed signs of decreased grip strength 1 week after
meniscectomy. From week 2 to 8, the grip strength of C rats was higher than that of H rats. In comparison
with H rats, HMA, HPA and HSA rats exhibited similar decreased grip strength and hence were not
different. In contrast, the HLA rats increased grip strength compared to H rats (Figure 2B). Similar
results were observed in terminal week (week 8) measurements, whereas HLA rats showed increased
grip strength compared to other SFA diet-fed rats (Figure 2E).
The results of the PAM which measures mechanical limb withdrawal threshold (LWT) were
consistent with von Frey and grip strength tests. C rats increased LWT in comparison with H rats.
HMA, HPA and HSA rats showed a gradual decrease in LWT from week 3 through to week 6 and
were quite similar to that of H rats, and hence were not different to each other. In contrast, HLA rats
showed an increase in LWT throughout the 8 weeks of OA progression compared to H rats (Figure 2C).
Similar results were observed in terminal week (week 8) measurements, where in HLA rats showed
increased LWT compared to other SFA diet-fed rats (Figure 2F).
3.3. Structural Changes in Knee Joints
3-Dimensional micro-CT scanning showed structural changes in the subchondral bone of OA
rats in the tibial plateau (Figure 3A). Examination of the subchondral bone showed that H rats had
reduced BV/TV compared to that of the C group rats. HLA and HMA rats exhibited increased BV/TV
compared to H rats, whereas the HPA and HSA rats showed no changes compared to H rats (Figure 3B).
Consistent with BV/TV results, BMD decreased in H rats in comparison with C rats. HPA and HSA
rats showed BMD similar to H rats, while HLA and HMA rats showed increased BMD compared to H
rats (Figure 3C).Nutrients 2019, 11, x FOR PEER REVIEW 9 of 16 
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Knees from post-meniscectomy rats exhibited OA-phenotypical cartilage changes, indicated
by increased degeneration of the cartilage layer, loss of proteoglycans and fibrillation, whereas the
sham-operated knees showed a normal appearance of the cartilage without any degeneration or
subchondral bone changes (Figure 4A). In the sham group, the joints from the C rats showed smooth
articular cartilage surface, normal cellularity and strong intensity of safranin-O staining. In contrast,
sham-operated H, HPA and HSA rats showed degenerative changes of the articular cartilage especially
in the surface zone, indicated by surface irregularity, loss of proteoglycans evidenced by weak
safranin-O staining and increased Mankin scores. In contrast, HMA and HLA sham-operated rats
showed cartilage structures, proteoglycan intensity and Mankin scores that were similar to C rats
(Figure 4A,B).Nutrients 2019, 11, x FOR PEER REVIEW 10 of 16 
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In post-meniscectomy rats, the joints were not visibly different, as all groups exhibited similar
damage (Figure 4A). Post-meniscectomy rats demonstrated erosion of the hyaline cartilage with
increased loss of proteoglycans from the extracellular matrix, as evident by the marked reduction of
safranin-O staining and increased Mankin scores compared to sham rats, independent of SFA treatment
(Figure 4A,B). The articular surface of post-meniscectomy rats of H, HLA, HMA, HPA and HSA groups
showed similar fissures, fibrillation and exposure of the subchondral bone, as well as the formation of
cysts and presence of osteophytes.
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3.4. Spinal Glial Cell Activation Post-Meniscectomy
In addition to pain behaviour, activation of spinal astrocyte and microglia was examined in
post-meniscectomy rats for evidence of astrogliosis and microgliosis in both SC and DRG. HPA and
HSA rats increased activation of astrocytes (GFAP) and microglia (IBA-1) in the SC and DRG and were
similar to the activation patterns of H rats. In contrast, HLA and HMA treatment reduced activation of
astrocytes and microglia in SC and DRG compared to H rats (Figures 5A and 6A).
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OA rats fed the different diets. Quantification of GFAP (B) and IBA-1 (C) mRNA levels in the DRG was
performed using qPCR. All values are represented as mean ± SD, n = 4. C, corn starch diet-fed rats; H,
high-carbohydrate high-fat diet-fed rats; HLA, high-carbohydrate high-lauric acid diet-fed rats; HMA,
high-carbohydrate high-myristic acid diet-fed rats; HPA, high-carbohydrate high-palmitic acid diet-fed
rats; HSA, high-carbohydrate high-stearic acid diet-fed rats.
The pain-associated proteins GFAP and IBA-1 which are upregulated during OA-induced knee
joint pain were assessed to determine whether activation of neuronal microglia and astrocytes was linked
with corresponding changes in the messenger RNA (mRNA) levels within the cellular components
of SC and DRG. Real-time PCR showed that the expression of both GFAP and IBA-1 in SC and DRG
was increased in H rats compared to C rats. The expression in H, HPA and HSA rats was similar but
in contrast, HLA and HMA rats had decreased expression in comparison to H rats (Figure 5B,C and
Figure 6B,C).
4. Discussion
OA is both an age- and mechanical- stress-related degenerative joint disease as well as a
metabolic disease with independent effects of diabetes, dyslipidaemia and hypertension to cartilage
degradation [3,22]. Animal models of OA may provide evidence for mechanisms of OA and possible
interventions but there is no single, widely-accepted animal model [23]. Surgical models in rats produce
joint instability, altered joint mechanics and local inflammation; these models are reproducible with
rapid onset and progression which may not fully mimic human OA [23]. Non-invasive monitoring with
magnetic resonance imaging of the femorotibial joint in rats following partial medial meniscectomy
showed progressive changes in cartilage related to trauma-induced OA [24]. More commonly, OA is
induced in rats by injection of monosodium iodoacetate into the knee or ankle joint [25]; however,
this intervention produces chondrocyte death rather than trauma-induced cartilage degeneration in
OA. Pain is a major characteristic of human knee OA, so measurement of pain in rat models of OA
is essential for translation to humans. The advantages and disadvantages of the methods used in
this project (von Frey, hind limb grip strength and mechanical pain threshold of the knee joint) have
been reviewed [26–28]; none are perfect matches to human OA pain, but they are widely accepted as
appropriate methods for use in rodents, for example in the testing of analgesics [29].
Chronic low-grade inflammation in obesity may worsen the damage and pain in OA [13,14].
Obesity-induced osteoarthritis in the knee can be modelled by surgery on rats with diet-induced
obesity [30]. Abdominal obesity is part of metabolic syndrome, together with hypertension,
hyperglycaemia, fatty liver, and inflammation, which increases the risk of cardiovascular disease and
diabetes; this syndrome is mimicked by a diet high in simple sugars, and saturated and trans fats in
rats [15]. The physiological changes in this validated dietary model of human metabolic syndrome in
rats can be reversed by dietary interventions such as the anthocyanin, cyanidin glucoside, from Queen
Garnet plums [31] and carrageenans from red seaweeds such as Sarconema filiforme [32].
This current study has combined partial medial meniscectomy of the right knee [24] together
with chronic consumption of fructose with beef tallow for a total of 24 weeks [16] to produce rats
with progressive trauma-induced OA and obesity. The results of this study indicate that chronic
consumption of beef tallow or its replacement by palmitic or stearic acids led to increased pain,
subchondral bone changes and metabolic syndrome parameters compared to replacement of beef
tallow with lauric or myristic acids. Similarly, our previous study for 16 weeks in obesity-induced
OA reported that lauric acid, the medium-chain SFA, showed preventive effects against diet-induced
obesity, cardiovascular and liver complications and OA development, whereas palmitic and stearic
acids as long-chain SFA increased these parameters [16]. Since lauric and myristic acids were oxidised
faster than palmitic and stearic acids [33], the oxidation rate of different SFA could be inversely related
to changes in body fat, and metabolic and organ functions, as well as OA development.
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Adipokines may provide the link between biomechanics, behaviour and inflammation as factors
in promoting obesity-associated OA, especially since OA is common in non-weight-bearing joints such
as hands and shoulders [34]. Beyond mechanical loading, adipokines modulate pro/anti-inflammatory
and anabolic/catabolic balance, apoptosis, matrix remodelling and subchondral bone ossification [35,36].
One important source of these cytokines to mediate inflammatory responses is the infrapatellar fat
pad [5]. Inflammation then drives sensitisation which is associated with pain severity and may
contribute to the transition from acute to chronic pain in knee osteoarthritis. IL-1β is one of the major
cytokines involved in the pathogenesis of OA, where it causes inflammatory reactions to the articular
cartilage [35,36]. In contrast, IL-10 has chondroprotective effects during OA pathogenesis which induces
the synthesis of aggrecan and type II collagen in the cartilage [35,36]. In our study, plasma concentrations
of pro-inflammatory cytokines (IL-1β and IFN-γ) were increased and an anti-inflammatory cytokine
(IL-10) was decreased in rats fed palmitic or stearic acids, suggesting excessive systemic inflammation.
The decreased expression of IL-1β and IFN-γ and increased expression of IL-10 in rats fed lauric
or myristic acids suggests a markedly reduced inflammatory response to these SFA. Changes in
pro-inflammatory cytokines may also relate to decreased body weight in rats fed lauric and myristic
acids; a meta-analysis demonstrated that a 5–10% decrease in body weight improved pain, self-reported
disability and quality of life in obese OA patients [37]. Further, other fatty acids, especially omega-3
polyunsaturated fatty acids, also show decreased inflammatory markers and cartilage degradation in
animals and humans [38].
One of our major findings was that post-meniscectomy rats, independent of diet group and
body weight, had similar Mankin scores. This suggests that body weight did not play a role in the
differences in cartilage degradation. The regions of the cartilage were equally damaged in response to
the different diets and hence we could not draw any correlation between degeneration of articular
cartilage, pain behaviour and inflammatory factors. In contrast, abnormalities in subchondral bone
during OA can promote development of joint pain [39,40], with our results showing post-traumatic
changes in the bone morphology that were exacerbated by palmitic and stearic acids.
Pain in OA is complex with both neuropathic and nociceptive mechanisms [41]. The behavioural
methods to measure stimulus-evoked and non-stimulus-evoked nociception in rodents have been
evaluated [26], justifying measurements with different methods as in this study. The behavioural
pain responses contributed by activation of spinal microglia and astrocytes show that there may be a
positive correlation between distal allodynia and spinal glial cells. The neural damage which arises
from the progressive degradation of cartilage induces a chronic state such as neuropathic pain [42].
Neuronal damage caused by the proliferation of microglia in the dorsal regions is one of the main
causative agents for the pathogenesis of neuropathic pain [43]. It is reported that spinal glial cells
contributed to pain behaviour in monoiodoacetate-induced OA in rats and therapy that alleviated OA
pain inhibited activated microglia and reduced astrocyte expression [44–46].
In this study, we observed impairments in both pain threshold (PWT and LWT) and grip strength
in post-meniscectomy rats fed SFA except HLA and C rats. Pain results from both increased nociceptive
inputs from the joints and also central sensitisation of the SC and the brain [44]. Allodynia from central
sensitisation could play an important role in the reduction of this pain threshold. The common drivers
of nociceptors associated with OA are the subchondral bone, muscle, ligaments and synovium [47,48].
The changes in expression of inflammatory mediators in response to different SFA diets could hold the
key to this finding, as HLA rats showed decreased pro-inflammatory cytokines. One major factor in the
interpretation of pain behaviour results in the study is lack of predictability of the link between pain
and structural changes in the knee clinically, except for the presence of osteophytes [49]. Moreover,
clinical studies have shown that weight loss in obese patients with knee OA relieves disability from
OA [37]. Nevertheless, more studies are required to elucidate the changes in pain behaviour in response
to high-fat diets, in particular related to the content of medium-chain rather than long-chain SFA.
The major limitation of this study is the unknown ability to translate results from this rat
model to obese humans with chronic progressive OA pain, and further to non-obese OA patients.
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The mechanisms of the responses need further investigation as this may provide targeted interventions
for pain relief. Possible targets include the local production of inflammatory mediators from the
infrapatellar fat pad [5] and changes in the intestinal microbiome [50], both of which may alter OA pain.
5. Conclusions
Our results indicate that dietary SFAs differentially influence both development of obesity and
pain behaviour in trauma- and obesity-induced OA, with medium-chain SFA having minimal effects
on both obesity and pain behaviour in contrast to longer-chain SFA. This suggests that altering dietary
SFA to medium-chain SFA may improve both obesity and pain behaviour, probably by altering
inflammatory mediators.
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